drugset / Trial / NCT00511810
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
Phase 2/3
Completed
20 enrolled
University of Cincinnati
The Inflammation Research Foundation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the study was to determine the effects of 10-week adjunctive supplementation with 2 doses of LCn-3 fatty acids (fish oil) on cortical functional activity and biochemistry in adolescents with MDD. The primary prediction was that LCn-3 fatty acid supplementation would dose-dependently increase prefrontal cortical functional activation during sustained attention and increase regional biochemical indices of cortical metabolism and integrity concentrations in association with reductions in depressive symptoms.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omega-3 fatty acids | Unknown | 2.4 g | — |
| Subject | Omega-3 fatty acids | Unknown | 15 g | — |